BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16566283)

  • 1. A clinical overview of azelaic acid.
    Elewski B; Thiboutot D
    Cutis; 2006 Feb; 77(2 Suppl):12-6. PubMed ID: 16566283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.
    Czernielewski J; Liu Y
    Arch Dermatol; 2004 Oct; 140(10):1282-3; author reply 1283. PubMed ID: 15492198
    [No Abstract]   [Full Text] [Related]  

  • 3. Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.
    Del Rosso JQ; Bhatia N
    Cutis; 2011 Aug; 88(2):67-72. PubMed ID: 21916272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rationale for advancing the formulation of azelaic acid vehicles.
    Draelos ZD
    Cutis; 2006 Feb; 77(2 Suppl):7-11. PubMed ID: 16566282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
    Wolf JE; Kerrouche N; Arsonnaud S
    Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials.
    Liu RH; Smith MK; Basta SA; Farmer ER
    Arch Dermatol; 2006 Aug; 142(8):1047-52. PubMed ID: 16924055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):s101-7. PubMed ID: 25607798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.
    Del Rosso JQ
    Cutis; 2006 Feb; 77(2 Suppl):22-4. PubMed ID: 16566285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
    Maddin S
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
    McGregor SP; Alinia H; Snyder A; Tuchayi SM; Fleischer A; Feldman SR
    Dermatol Clin; 2018 Apr; 36(2):135-150. PubMed ID: 29499797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.
    Draelos ZD; Elewski B; Staedtler G; Havlickova B
    Cutis; 2013 Dec; 92(6):306-17. PubMed ID: 24416747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea.
    Wirth PJ; Henderson Berg MH; Sadick N
    Skin Therapy Lett; 2017 Nov; 22(6):5-7. PubMed ID: 29091380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rigor of trials evaluating Rosacea treatments.
    van Zuuren EJ; Graber MA
    Cutis; 2005 Mar; 75(3 Suppl):13-6; discussion 33-6. PubMed ID: 15810805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azelaic acid (Finacea) for rosacea.
    Med Lett Drugs Ther; 2003 Sep; 45(1165):76. PubMed ID: 12968125
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study.
    Del Rosso JQ
    Cutis; 2009 Aug; 84(2):72-6. PubMed ID: 19746764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A status report on the medical management of rosacea: focus on topical therapies.
    Del Rosso JQ
    Cutis; 2002 Nov; 70(5):271-5. PubMed ID: 12469780
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
    Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
    J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case studies.
    Bikowski JB
    Cutis; 2006 Feb; 77(2 Suppl):17-21. PubMed ID: 16566284
    [No Abstract]   [Full Text] [Related]  

  • 20. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.